Bausch Health Companies (TSE:BHC) Sets New 12-Month High at $15.43

Bausch Health Companies Inc. (TSE:BHCGet Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$15.43 and last traded at C$13.55, with a volume of 362608 shares changing hands. The stock had previously closed at C$13.83.

Analysts Set New Price Targets

Separately, Royal Bank of Canada increased their price objective on Bausch Health Companies from C$8.00 to C$9.00 and gave the stock a “sector perform” rating in a research report on Friday, February 23rd.

Read Our Latest Research Report on Bausch Health Companies

Bausch Health Companies Stock Down 1.7 %

The firm’s 50 day simple moving average is C$12.17 and its two-hundred day simple moving average is C$10.92. The firm has a market cap of C$4.97 billion, a price-to-earnings ratio of -6.29, a PEG ratio of 0.21 and a beta of 0.83. The company has a current ratio of 1.30, a quick ratio of 0.58 and a debt-to-equity ratio of 7,583.76.

Bausch Health Companies (TSE:BHCGet Free Report) last issued its quarterly earnings results on Thursday, February 22nd. The company reported C$1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of C$1.36 by C$0.19. The business had revenue of C$3.28 billion during the quarter, compared to analysts’ expectations of C$3.05 billion. Bausch Health Companies had a negative return on equity of 686.52% and a negative net margin of 6.76%. On average, equities analysts forecast that Bausch Health Companies Inc. will post 4.9653979 EPS for the current year.

Bausch Health Companies Company Profile

(Get Free Report)

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

See Also

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with's FREE daily email newsletter.